USANA Health Sciences, Inc. (NYSE:USNA) major shareholder Global Ltd Gull sold 79,294 shares of the firm’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $57.61, for a total value of $4,568,127.34. Following the completion of the sale, the insider now directly owns 12,272,013 shares in the company, valued at $706,990,668.93. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Global Ltd Gull also recently made the following trade(s):

  • On Tuesday, September 5th, Global Ltd Gull sold 40,000 shares of USANA Health Sciences stock. The shares were sold at an average price of $58.41, for a total value of $2,336,400.00.
  • On Wednesday, August 2nd, Global Ltd Gull sold 14,533 shares of USANA Health Sciences stock. The shares were sold at an average price of $56.71, for a total value of $824,166.43.
  • On Tuesday, August 1st, Global Ltd Gull sold 25,467 shares of USANA Health Sciences stock. The shares were sold at an average price of $56.52, for a total value of $1,439,394.84.

Shares of USANA Health Sciences, Inc. (NYSE USNA) opened at 57.00 on Friday. The stock’s 50 day moving average price is $57.61 and its 200-day moving average price is $60.16. The firm has a market capitalization of $1.39 billion, a price-to-earnings ratio of 14.81 and a beta of 1.10. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $75.00.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, July 25th. The company reported $0.98 EPS for the quarter, missing the consensus estimate of $1.06 by ($0.08). The firm had revenue of $257.10 million for the quarter, compared to the consensus estimate of $273.61 million. USANA Health Sciences had a net margin of 9.47% and a return on equity of 28.93%. USANA Health Sciences’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter last year, the company posted $2.07 earnings per share. Equities analysts predict that USANA Health Sciences, Inc. will post $3.79 earnings per share for the current year.

USANA Health Sciences declared that its Board of Directors has approved a stock repurchase plan on Tuesday, July 25th that permits the company to buyback $64.60 million in outstanding shares. This buyback authorization permits the company to repurchase up to 46% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its shares are undervalued.

TRADEMARK VIOLATION NOTICE: “Insider Selling: USANA Health Sciences, Inc. (USNA) Major Shareholder Sells $4,568,127.34 in Stock” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://www.thecerbatgem.com/2017/09/17/insider-selling-usana-health-sciences-inc-usna-major-shareholder-sells-4568127-34-in-stock.html.

A number of brokerages have recently commented on USNA. BidaskClub raised USANA Health Sciences from a “hold” rating to a “buy” rating in a research note on Tuesday, June 13th. Pivotal Research cut their price target on USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating on the stock in a research note on Wednesday, July 26th.

Institutional investors have recently made changes to their positions in the company. BNP Paribas Arbitrage SA increased its position in shares of USANA Health Sciences by 13.1% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock valued at $135,000 after purchasing an additional 245 shares during the last quarter. Victory Capital Management Inc. increased its position in shares of USANA Health Sciences by 124.7% during the 1st quarter. Victory Capital Management Inc. now owns 2,117 shares of the company’s stock valued at $122,000 after purchasing an additional 1,175 shares during the last quarter. Creative Planning increased its position in shares of USANA Health Sciences by 528.0% during the 2nd quarter. Creative Planning now owns 2,512 shares of the company’s stock valued at $161,000 after purchasing an additional 2,112 shares during the last quarter. SG Americas Securities LLC bought a new position in shares of USANA Health Sciences during the 2nd quarter valued at about $162,000. Finally, Eqis Capital Management Inc. bought a new position in shares of USANA Health Sciences during the 2nd quarter valued at about $210,000. Hedge funds and other institutional investors own 44.90% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Stock Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related stocks with our FREE daily email newsletter.